Medicine and Dentistry
Transitional Cell Carcinoma
100%
Nephroureterectomy
64%
Overall Survival
32%
Recurrent Disease
32%
Cohort Analysis
29%
Prostate Cancer
29%
Bladder
28%
Urinary System
24%
Urothelial Cancer
23%
Cancer Specific Survival
23%
Disease Free Survival
23%
Symptom
21%
Neoplasm
19%
Upper Urinary Tract
19%
Inguinal Hernia
18%
Uropathogenic Escherichia Coli
17%
Bladder Cancer
16%
Hydronephrosis
15%
Recurrence Free Survival
14%
Treatment Response
14%
Cardiovascular Disease
14%
Malignant Neoplasm
13%
Herniorrhaphy
12%
Signal Transduction
12%
Disease
12%
Erectile Dysfunction
12%
Infection
12%
Meta-Analysis
11%
Prostate Cell
11%
Percutaneous Nephrolithotomy
11%
Adjuvant Chemotherapy
11%
Methylation
11%
Clear Cell Renal Cell Carcinoma
11%
Ureter Tumor
10%
Hernia
10%
Proportional Hazards Model
9%
Hazard Ratio
9%
Prevalence
9%
Metastatic Carcinoma
9%
Chronic Kidney Disease
9%
Pelvic Tumor
9%
Postoperative Complication
8%
Operation Duration
8%
Injury
8%
Survival Rate
8%
Urinary Tract
8%
Hernioplasty
8%
Androgen Deficiency
8%
Varicocelectomy
7%
Urolithiasis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
70%
Prostate Cancer
29%
Recurrent Disease
21%
Malignant Neoplasm
20%
Neoplasm
19%
Renal Cell Carcinoma
17%
Uropathogenic Escherichia Coli
17%
Cigarette Smoking
16%
Tumor Necrosis Factor
16%
Overall Survival
15%
Bladder Cancer
14%
Androgen
12%
Chemotherapy
12%
Interleukin 8
11%
Infection
11%
Castration Resistant Prostate Cancer
11%
Case-Control Study
10%
Arginine
10%
Disease Exacerbation
9%
Prostate Specific Antigen
8%
Disease
8%
Inflammation
7%
Enzalutamide
6%
Cardiovascular Disease
6%
Pelvis Pain Syndrome
6%
Pain
5%
Cohort Study
5%
Focal Glomerulosclerosis
5%
Phosphodiesterase V Inhibitor
5%
Sulfotransferase 1A1
5%
Glutathione
5%
8 Hydroxydeoxyguanosine
5%
Vardenafil
5%
Nicotine-Derived Nitrosamine Ketone
5%
Endometriosis
5%
Mediator Complex
5%
Apoptosis Inhibitor
5%
Chronic Prostatitis
5%
Toll Like Receptor 4
5%
End Stage Renal Disease
5%
Mouse Model
5%
Pembrolizumab
5%
Carcinogenicity
5%
Hydronephrosis
5%
Atrial Fibrillation
5%
Phimosis
5%
Biochemical Recurrence
5%
Transferase
5%
Protein P53
5%
Alpha Tocopherol
5%
Biochemistry, Genetics and Molecular Biology
Uropathogenic Escherichia Coli
17%
Tumor Necrosis Factor
14%
Genotyping
13%
Passive Smoking
13%
Signal Transduction
12%
Interleukin 8
12%
Gene Promoter
11%
Tumor Necrosis Factor Alpha
11%
Case-Control Study
10%
Cigarette Smoking
10%
Overall Survival
9%
Prostate-Specific Antigen
9%
Tumor Volume
8%
STAT1
8%
Vascular Endothelial Growth Factor
7%
Enzalutamide
6%
Upregulation
6%
Anticancer
6%
SRD5A1
5%
SOX2
5%
Shear Stress
5%
Survivin
5%
Genetics
5%
Gleason Score
5%
Metabolomics
5%
Promoter Region
5%
Testosterone Blood Level
5%
Mediator Complex
5%
STAT3
5%
Cohort Study
5%
Methylation
5%
Survival Rate
5%
Disease Free Survival
5%
Mortality Rate
5%
SARS Coronavirus
5%
Coronavirinae
5%
Pembrolizumab
5%
Interleukin 6
5%
Helicobacter Pylori
5%
TLR4
5%
Inhibitor of Apoptosis
5%
Macrophage
5%
Smoking
5%
Cancer Cell
5%
